North America Invasive Neurostimulation Devices Industry Projected to Reach US$ 5.95 Billion by 2033
The North America invasive neurostimulation devices industry is witnessing strong expansion as healthcare providers increasingly adopt implantable neuromodulation technologies for the treatment of chronic pain, Parkinson’s disease, epilepsy, movement disorders, and other complex neurological conditions. Invasive neurostimulation devices deliver targeted electrical impulses to specific...
0 Comments 0 Shares 108 Views 0 Reviews